Molecular Diagnostics Market 2015 Update: Deal Trends, Cancer Testing, Strategic Assessments of Major Suppliers and More in New Research Reports

Aug 10, 2015, 02:00 ET from Life Science Industry Research

CHICAGO, August 10, 2015 /PRNewswire/ --

LifeScienceIndustryResearch.com adds 2015 molecular diagnostics market research reports that focus on role of MD in cancer testing, provide 5 Year deal trends details along with information on players, financials, forecasts as well as strategic assessments of major suppliers.

Complete report on Global Molecular Diagnostics Market 2010-2015: Deal trends, players, financials and forecasts spread across 512 pages, providing a partnering contracts and dealmaking directory as well as supported with 36 figures is now available at http://www.lifescienceindustryresearch.com/molecular-diagnostics-partnering-terms-and-agreements.html .

This report provides details of the latest molecular diagnostics market agreements announced in the healthcare sectors. It contains a comprehensive listing of all molecular diagnostics partnering deals announced since 2010 including financial terms, wherever available, including over 300 links to online deal records of actual molecular diagnostics partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

A popular chapter with readers of this molecular diagnostics market 2015 report covers the average financial deal terms for deals signed in the molecular diagnostics field with a stage of development announced. Deals are listed and sectioned by average headlines, upfront payments, milestone payments and royalty rates. The median values of these deals are then presented by stage of development at signing. Numerous tables and figures are weaved within the report to support the findings and illustrate the trends and activities in molecular diagnostics partnering and dealmaking since 2010. Order a copy of Global Molecular Diagnostics 2010-2015: Deal trends, players, financials and forecasts report at http://www.lifescienceindustryresearch.com/purchase?rname=23823 .

A full appendix is provided at the very end of the report which lists all the cancer diagnostics deals announced since 2010 categorized by company A-Z, deal type, stage of development, technology and therapy. Where available contract documents are supplied, these documents include additional deal information in comparison to only the brief summary that is provided through a press release. Readers can analyze the contracts fully by reviewing the detailed terms between the parties under which monies and licensing rights are exchanged. The appendix is useful for looking at all the deals signed by one specific company.

Specifically for the diagnostics market and in general for the overall healthcare industry, LifeScienceIndustryResearch.com offers a wide range of newly published and relevant research titles:

Molecular Diagnostics in Cancer Testing: This research report describes the specific segment of the in vitro diagnostics (IVD) market known as molecular diagnostics (MD), with a specialization in the MD tests for cancer. In the current medical diagnostics market, molecular diagnostics for cancer testing offers one of the brightest areas for growth and innovation. The confluence of breakthroughs in genomics, proteomics, and the development of microarray devices to measure analytes in the blood and various body tissues, has led to this revolutionary market segment offering the power of advanced analytical techniques to the diagnosis and treatment of cancer. This report analyzes the size and growth of the molecular diagnostics market in its applications for cancer detection and therapy, examining the factors that influence the various market segments and the dollar volume of sales, both in the United States and worldwide.

Companies profiled in the molecular diagnostics in cancer testing market research report include Abbott Molecular Diagnostics, Accugenomics, Inc., Agendia, Ambry Genetics, Biodesix, bioMérieux, bioTheranostics (AviaraDx), Cancer Genetics, Inc., Clarient, Inc. (GE Healthcare), Counsyl , Flatiron Health, Epigenomics, Exact Sciences Corporation, Exiqon, Genomic Health, Inc., Genoptix, Inc. (Novartis), Genmark Diagnostics, Genomictree, HTG Molecular Diagnostics, Invitae, LabCorp, Myriad Genetics, Inc., Nanostring, Neogenomics, NSTG, Nuvera Biosciences, Orion Genomics, Pathway Genomics, Personal Genome Diagnostics, Quest Diagnostics, Rosetta Genomics Ltd., Signal Genetics, Source MDx 225 and Wilex, Inc.. Comprehensive table of contents and more on this research is available at http://www.lifescienceindustryresearch.com/molecular-diagnostics-in-cancer-testing.html .

CompetitiveWatch Molecular Diagnostics 2015: Strategic Assessments of Major Suppliers: This research presents insightful analyses of major current and emerging suppliers of molecular diagnostic products in terms of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Companies covered include Abbott, Affymetrix, Agilent Technologies, Applied Gene Technologies, Arca Biopharma, Beckman Coulter/Danaher, Becton Dickinson, Biokit, BioMerieux, Bio-Rad, Biotest, Cepheid, CellMark Forenciscs/LabCorp, Decode Genetics, Diadexus, Eiken, Elitech Group, Enzo, Exact Sciences, Fujirebio, Grifols, Hologic/Gen-Probe, Illumina, Kreatech/Leica, Li-Cor Biosciences, Monogram Biosciences/LabCorp, Myriad Genetics, Ortho-Clinical Diagnostics, Perkin Elmer/Caliper, Proteome Sciences, Qiagen, Roche, Scienion, Sequenom, Shimadzu, Siemens, Sierra Molecular, Takara Bio, Tecan Group and Thermo Fisher. Complete report is available at http://www.lifescienceindustryresearch.com/competitivewatch-molecular-diagnostics-2015-strategic-assessments-of-major-s    uppliers.html .

About Us:  

Life Science Industry Research brings to you the latest reports in market research on Biotechnology, Diagnostics, Healthcare, Medical Devices and Pharmaceuticals segments from leading research publishers across the globe. These reports also cover data and information on sub-segments and sectors under these life sciences categories.

Connect with Us: 

G+ / Google Plus: https://plus.google.com/112612135957880308475/about

Twitter: https://twitter.com/LifeSciReports

RSS / Feeds: http://www.lifescienceindustryresearch.com/feed

Contact:
Ritesh Tiwari
1 South Dearborn Street,
21st Floor, Chicago,
Illinois, 60603,
United States
Tel: +1-888-391-5441
sales@lifescienceindustryresearch.com


SOURCE Life Science Industry Research